Serial 98627503
Live / Applied — First extension granted (statement of use) (as of 31 Mar 2026)
What this means for you
Not registered yet, but its 01 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98627503
- Mark type
- Design / logo
- Filed
- 01 Jul 2024
- Published for opposition
- 19 Aug 2025
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the prevention and treatment of hormonal, genetic, and endocrine diseases, disorders, and conditions; pharmaceutical preparations for human use for the treatment of rare and orphan hormonal and genetic diseases, disorders, and conditions; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 02 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Mar 2026 — SOU EXTENSION 1 GRANTED
- 31 Mar 2026 — SOU EXTENSION 1 FILED
- 31 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 14 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Aug 2025 — PUBLISHED FOR OPPOSITION
- 13 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Jul 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED